Vyne Therapeutics Inc (VYNE) stock news · rev $570.0K
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
This VYNE news page leads with what Vyne Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for VYNE yet. We will not pad this page with generic market recap.
Latest reported VYNE revenue for 2025-12-31 was $570.0K. Net income was -$26.5M. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. VYNE currently screens at market cap $21.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VYNE stock page; for the tape open the quote page.
VYNE stock news FAQ
What are VYNE's latest revenue and net income?
Latest cached Vyne Therapeutics Inc (VYNE) revenue for Dec 31, 2025 was $570.0K. Net income was -$26.5M. Statements: https://lician.com/financials/vyne
How did VYNE revenue change from the prior cached period?
Cached Vyne Therapeutics Inc (VYNE) revenue was up 13.8% from $501.0K (Dec 31, 2024) to $570.0K (Dec 31, 2025). Statements: https://lician.com/financials/vyne
What is VYNE's market cap?
Vyne Therapeutics Inc (VYNE) market cap is $21.1M on the latest cached fundamentals snapshot.
What kind of company is VYNE?
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Where is VYNE stock news listed?
Cached stock news for Vyne Therapeutics Inc (VYNE) is listed at https://lician.com/news/vyne. Filings: https://lician.com/sec/vyne
Not investment advice.